Company Filing History:
1 out of 4 
1 out of 7 
1 out of 1 Years Active: 1989-1990
Title: Ron Breiman: Innovator in Cardiac Arrhythmia Treatment
Introduction
Ron Breiman is a notable inventor based in Tel Aviv, Israel. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cardiac arrhythmia. With a total of 2 patents, his work has the potential to impact many lives.
Latest Patents
Breiman's latest patents include innovative compounds known as 2-alkyl-3-benzoylbenzofurans. These compounds are specifically designed for treating cardiac arrhythmia. The first patent details new 2-alkyl-3-(4-hydroxy-3,5-di-tert-butylbenzoyl)benzofurans, along with pharmaceutical compositions that utilize these benzofurans and methods for treating cardiac arrhythmia. The second patent focuses on 2-alkyl-3-[4-(omega-N,N-dialkylaminoacylamino)-3,5-dialkylbenzoyl]benzofurans, also aimed at treating cardiac arrhythmia, along with related pharmaceutical compositions and treatment methods.
Career Highlights
Throughout his career, Breiman has worked with prominent companies in the pharmaceutical industry, including Taro Pharmaceuticals Inc. and Taro Pharmaceuticals Industries. His experience in these organizations has contributed to his expertise in developing effective treatments for cardiac conditions.
Collaborations
Breiman has collaborated with notable professionals in his field, including Barrie Levitt and Morris Stolar. These partnerships have likely enhanced his research and development efforts.
Conclusion
Ron Breiman's innovative work in the field of cardiac arrhythmia treatment showcases his dedication to improving healthcare through pharmaceutical advancements. His patents represent a significant step forward in the development of effective treatments for this condition.